Analysis of drug authentication at the point of dispensing in Belgian and Greek community pharmacies

Annals of Pharmacotherapy

Volumn 43, Issue 10, 2009, Pages 1701-1706

  Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Community pharmacy; Costs; Drug authentication; Effectiveness; Mass serialization; Reliability

Indexed keywords

ILLICIT DRUG;

ARTICLE; BELGIUM; COST BENEFIT ANALYSIS; DRUG AUTHENTICATION; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GREECE; HEALTH CARE COST; HEALTH PROGRAM; LAW SUIT; MEDICAL AUDIT; PHARMACY; PRIORITY JOURNAL; RELIABILITY;

BELGIUM; COMMUNITY PHARMACY SERVICES; COST-BENEFIT ANALYSIS; DRUG RECALLS; FRAUD; GREECE; HUMANS; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 70449494152     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M215     Document Type: Article

References (9)

1. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med 2005;2:e100. (accessed 2009 May 25). DOI10.1371/journal.pmed. 0020100
2. European Commission. Summary of community customs activities on counterfeit and piracy. Results at the European border-2007. Brussels: European Commission, 2008.
3. Harper J, Morris J, Satchwell G, Stevens P, Taylor D, Tremblay M. Coincidence or crisis? Prescription medicine counterfeiting. London: The Stockholm Network, 2006.
4. Franklin BD, O'Grady K. Dispensing errors in community pharmacy: frequency, clinical significance and potential impact of authentication at the point of dispensing. Int J Pharm Pract 2007;15:273-281 (Pubitemid 350247624)
5. Ball MJ, Douglas JV. Redefining and improving patient safety. Methods Inf Med 2003;41:271-276
6. Association Pharmaceutique Belge. Liste de retrait (extraction list). Brussels: Association Pharmaceutique Belge, 2008.
7. National Organisation for Medicines. Recalled medicines. Athens: National Organisation for Medicines, 2008.
8. Frost & Sullivan. Mass serialisation in the European pharmaceutical industry. Working together on mass serialisation: whose responsibility is ensuring patient safety? London: Frost & Sullivan, 2008.
9. European Commission. Impact assessment. Proposal for a Directive of the European Parliament and of the Council amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of medicinal products which are falsified in relation to their identity, history or source. Brussels: European Commission, 2008.